Both the CD44 and KLK3 genes are important in the development of PCa disease and although they are well studied, alternative splicing events are highly complex, and not only have polymorphisms been reported that modify the dynamics of splicing, It has also been seen that this modification can be orchestrated by epigenetic mutations and therefore are not very useful as a therapeutic target. The gene discussed is CD44; the disease is posterior cortical atrophy.